Evidence map›Paper›PMID 34782399›Full record

ArticleJournal of neurointerventional surgery2022

Diversion-p64: results from an international, prospective, multicenter, single-arm post-market study to assess the safety and effectiveness of the p64 flow modulation device.

Alain Bonafe, Marta Aguilar Perez, Hans Henkes, Pedro Lylyk, Carlos Bleise, Gregory Gascou, Stanimir Sirakov, Alexander Sirakov, Luc Stockx, Francis Turjman and 22 more

Registry-linked trialOpen access · hybridAbstract readMulticenter Study
In one paragraph

Article in Journal of neurointerventional surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06201598 (Prospective, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Endovascular Treatment in Patients With Cerebral Aneurysms Using P64 and P48 Flow-Diverter Stents), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06201598 recruitingnot on this mapstarted 2024, after this paper: background citation

Prospective, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Endovascular Treatment in Patients With Cerebral Aneurysms Using P64 and P48 Flow-Diverter Stents

TypeobservationalSponsorHospital Universitario Central de AsturiasRan2024 to 2025Enrolled100ConditionsCerebral Aneurysm, Thromboembolic DiseaseArmsGroup 1 - Intervention 1
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Comaneci stent-angioplasty for the optimization of inadequately deployed flow diverter stents.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2026
    Article
  5. Multicenter study of the safety and effectiveness of intracranial aneurysm treatment with the p64MW-HPC flow modulation device.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2026
    Article
  6. Flow diverter surface modifications for aneurysm treatment: A review of the mechanisms and data behind existing technologies.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2026
    Review
  7. Review
  8. The use of FD-HPC in Ruptured and Unruptured Aneurysms, the Italian Dataset (RUAID): Preliminary results on feasibility and safety.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025
    Article
  9. Article
  10. Multicenter study of HPC coated p48 and p64 flow diverters for treatment of intracranial aneurysms under dual antiplatelet therapy.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025
    Article
  11. Observational
  12. The DERIVO®2 Embolization Device in the treatment of ruptured and unruptured intracranial aneurysms: A multicenter analysis.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Safety and efficacy of the surpass streamline for intracranial aneurysms (SESSIA): A multi-center US experience pooled analysis.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2023
    Article
  17. Article
  18. Article
  19. Intrasaccular neck-bridging: A technical note on Nautilus-assisted coiling of wide-necked cerebral aneurysms. Feasibility study, immediate and early angiographic results.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2022
    Article
  20. Will Coiling Survive through the Next Decade?Journal of clinical medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 20 institutions in 9 countries.

Alain BonafeDepartment of Neuroradiology, Hopital Gui de Chauliac, Montpellier, France a-bonafe@chu-montpellier.fr.ORCID http://orcid.org/0000-0002-9187-1375
Marta Aguilar PerezNeuroradiologische Klinik, Klinikum Stuttgart, Stuttgart, Baden-Württemberg, Germany.
Hans HenkesNeuroradiologische Klinik, Klinikum Stuttgart, Stuttgart, Baden-Württemberg, Germany.ORCID http://orcid.org/0000-0002-6534-036X
Pedro LylykDepartamento de Neurociencias, ENERI, Clínica La Sagrada Familia, Buenos Aires, Argentina.
Carlos BleiseDepartamento de Neurociencias, ENERI, Clínica La Sagrada Familia, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0003-2292-3263
Gregory GascouDepartment of Neuroradiology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.ORCID http://orcid.org/0000-0002-0817-7324
Stanimir SirakovDepartment of Radiology, University Hospital St Ivan Rilski, Sofia, Bulgaria.ORCID http://orcid.org/0000-0001-6034-5340
Alexander SirakovDepartment of Radiology, University Hospital St Ivan Rilski, Sofia, Bulgaria.
Luc StockxNeuroradiology, Ziekenhuis Oost-Limburg - Campus Sint Jan, Genk, Belgium.
Francis TurjmanDepartment of Interventional Neuroradiology, Hôpital Neurologique Pierre Wertheimer, Lyon, France.
Andrey PetrovDepartment of Vascular Neurosurgery, Russian Polenov Neurosurgical Institute, Federal Almazov North West Medical Research Centre, St Petersburg, Russian Federation.
Christian RothDepartment of Diagnostic and Interventional Neuroradiology, Klinikum Bremen-Mitte gGmbH, Bremen, Germany.
Ana-Paula NarataDepartment of Interventional Neuroradiology, Regional University Hospital, Tours, France.
Xavier BarreauDepartment of Neuroradiology, Centre Hospitalier Universitaire de Bordeaux Groupe hospitalier Pellegrin, Bordeaux, France.
Christian LoehrDepartment of Radiology and Neuroradiology, Klinikum Vest GmbH Behandlungszentrum Knappschaftskrankenhaus Recklinghausen, Recklinghausen, Nordrhein-Westfalen, Germany.
Ansgar BerlisDepartment of Diagnostic and Interventional Neuroradiology, Klinikum Augsburg, Augsburg, Bayern, Germany.
Laurent PierotDepartment of Neuroradiology, Hôpital Maison Blanche, Reims, France.ORCID http://orcid.org/0000-0002-6893-661X
Marcin MiśDepartment of General Radiology, Interventional Radiology, and Neuroradiology, Wroclaw Medical University, Wroclaw, Dolnoslaskie, Poland.
Tony GoddardDepartment of Neuroradiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.ORCID http://orcid.org/0000-0001-6104-5606
Andy CliftonDepartment of Neuroradiology, St George's Hospital, London, UK.
Joachim KlischDepartment of Neuroradiology, HELIOS Klinikum Erfurt, Erfurt, Thüringen, Germany.
Cezary WałęsaNeuroradiology, Regionalny Szpital Specjalistyczny im dr Wl Bieganskiego, Grudziadz, Poland.
Massimo Dall'OlioNeuroradiology, Ospedale Bellaria Carlo Alberto Pizzardi, Bologna, Italy.
Laurent SpelleDepartment of Interventional Neuroradiology, BICETRE HOSPITAL - APHP, Le Kremlin-Bicetre, France.ORCID http://orcid.org/0000-0002-6748-8528
Frédéric ClarenconDepartment of Neuroradiology, Hôpital Universitaire Pitié Salpêtrière Service de Neuroradiologie Interventionnelle, Paris, Île-de-France, France.
Sergey YakovlevNeuroradiology, Burdenko Neurosurgical Clinic, Moskva, Russian Federation.
Peter KestonDepartment of Clinical Neuroscience, NHS Lothian, Edinburgh, UK.
Nunzio Paolo NuzziNeuroradiologia Interventistica, IRCCS Istituto Clinico Humanitas, Rozzano, Lombardia, Italy.
Stefanita DimaClinica de Neurochirurgie si Terapie Endovasculara Neurolife, Life Memorial Hospital, Bucharest, Romania.
Christina WendlInstitut für Röntgendiagnostik, Universitatsklinikum Regensburg, Regensburg, Bayern, Germany.
Tine WillemsT!Write, Vaartstraat 78, 9270, Kalken, Belgium.
Peter SchrammDepartment of Neuroradiology, Universitätsklinikum Schleswig-Holstein Campus Lübeck, Lubeck, Schleswig-Holstein, Germany.
Instituto Cardiovascular de Rosario · ARKlinikum Stuttgart · DEUniversity Hospital St. Ivan Rilski · BGBurdenko Neurosurgery Institute · RUCentre Hospitalier Universitaire de Bordeaux · FRCentre Hospitalier Universitaire de Montpellier · FRCentre Hospitalier Universitaire de Reims · FRFederal Almazov North-West Medical Research Centre · RUHelios Klinikum Erfurt · DEHôpital Gui de Chauliac · FRHôpital Pierre Wertheimer · FRIRCCS Humanitas Research Hospital · ITKlinikum Bremen-Mitte · DEKlinikum Vest · DELeeds Teaching Hospitals NHS Trust · GBMiędzyleski Szpital Specjalistyczny w Warszawie · PLNHS Lothian · GBOspedale Bellaria · ITSt George's Hospital · GBUniversité Paris-Saclay · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of flow diversion to treat intracranial aneurysms has increased in recent years.

objectiveTo assess the safety and angiographic efficacy of the p64 flow modulation device.

methodsDiversion-p64 is an international, prospective, multicenter, single-arm, study conducted at 26 centers. The p64 flow modulation device was used to treat anterior circulation aneurysms between December 2015 and January 2019. The primary safety endpoint was the incidence of major stroke or neurologic death at 3-6 months, with the primary efficacy endpoint being complete aneurysm occlusion (Raymond-Roy Occlusion Classification 1) on follow-up angiography.

resultsA total of 420 patients met the eligibility criteria and underwent treatment with the p64 flow modulation device (mean age 55±12.0 years, 86.2% female). Mean aneurysm dome width was 6.99±5.28 mm and neck width 4.47±2.28 mm. Mean number of devices implanted per patient was 1.06±0.47, with adjunctive coiling performed in 14.0% of the cases. At the second angiographic follow-up (mean 375±73 days), available for 343 patients (81.7%), complete aneurysm occlusion was seen in 287 (83.7%) patients. Safety data were available for 413 patients (98.3%) at the first follow-up (mean 145±43 days) with a composite morbidity/mortality rate of 2.42% (n=10).

conclusionsDiversion-p64 is the largest prospective study using the p64 flow modulation device. The results of this study demonstrate that the device has a high efficacy and carries a low rate of mortality and permanent morbidity.

Indexed as

Embolization, TherapeuticEndovascular ProceduresIntracranial AneurysmAdultAgedCerebral AngiographyFemaleFollow-Up StudiesHumansMaleMiddle AgedProspective StudiesRetrospective StudiesStentsTreatment Outcomeaneurysmflow diverterstent

Identifiers

PMID34782399
PMCPMC9380510
OpenAlexW3211478905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.